CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells
复制标题
DOI:
10.1182/blood-2006-03-008441
复制
发表时间:
2007-02-15
期刊:
影响因子:
20.3
通讯作者:
Zand, Martin S.
中科院分区:
文献类型:
--
作者:
Huggins, Jennifer;Pellegrin, Tina;Zand, Martin S.
Unmethylated CpG DNA activation of naive CD27(-) B cells has been reported to require B-cell-receptor (BCR) cross-linking. We describe a culture system using CpG DNA with sequential steps for T-cell-independent activation of naive CD19(+)CD27(-) human peripheral blood B cells that induces efficient CD138(+) plasma-cell differentiation. CD27(+) and CD27- B cells were cultured in a 3-step system: (1) days 0 to 4: CpG, IL-2/10/15; (2) days 4 to 7: IL-2/6110/15 and anti-CD40L; (3) days 7 to 10: IL-6/15, IFN-alpha, hepatocyte growth factor, and hyaluronic acid. Both CD27+ and CD27- B cells up-regulated intracytoplasmic TLR-9 following CpG DNA activation. CD27- B-cell activation required cell-cell contact. Both naive and memory B cells progressed to a plasma-cell phenotype: CD19(low)CD20(low)CD27(+)CD38(+)HLA-DRlow. Seventy percent of the CD27-derived CD138(+) cells demonstrated productive V chain rearrangements without somatic mutations, confirming their origin from naive precursors. Plasma cells derived from CD27(+) B cells were primarily IgG(+), while those from CD27(-) B cells were IgM(+). Our results indicate that under certain conditions, naive B cells increase TLR-9 expression and proliferate to CpG DNA stimulation without BCR signaling. In addition to its immunologic significance, this system should be a valuable method to interrogate the antigenic specificity of naive B cells.